BioHarvest Sciences completed Stage 1 of its $1.125 million CDMO development agreement with SaffronTech, advancing to Stage 2 for sustainable saffron production and retaining 25% ownership plus future royalties.
Key takeaways
Completed Stage 1, establishing stable saffron cell bank with key bioactives crocin, picrocrocin, and safranal.
Advanced to Stage 2 to generate biomass for pre-commercial testing using Botanical Synthesis platform.
Development agreement valued at $1.125 million with SaffronTech.
Holds 25% ownership in saffron composition and future manufacturing royalties.
Addresses saffron supply constraints; global production 500-600 metric tons annually.
Strengthens CDMO division for supply-constrained botanicals.